FcγRIIB expressed on CD8(+) T cells limits responsiveness to PD-1 checkpoint inhibition in cancer.
Bennion KB, Tariq M, Wyatt MM, Duneton C, Baecher KM, Paulos CM, Kudchadkar RR, Lowe MC, Ford ML. Sci Transl Med. 2023 Aug 23; 15(710):eadd1868. Epub 2023 Aug 23.